Search for Clinical Trial Results
Ebola Virus Disease - 26 Studies Found
Status | Study |
Completed |
Study Name: Efficacy of Favipiravir Against Severe Ebola Virus Disease Condition: Ebola Virus Disease Date: 2016-01-19 Interventions:
|
Recruiting |
Study Name: PREVAIL VI: Identification of Host Genetic Factors Underlying Ebola Virus Disease Risk, Mortality, Long-term Sequelae, Viral RNA Persistence, Humoral Immunity, and Ebola Vaccine Response Condition: Ebola Virus Disease Date: 2017-03-30 |
Recruiting |
Study Name: Multiple Treatments for Ebola Virus Disease (EVD) Condition: Ebola Virus Disease Date: 2015-03-01 Interventions:
|
Recruiting |
Study Name: Partnership for Research on Ebola VACcinations Condition: Ebola Virus Disease Date: 2016-08-16 Interventions:
|
Enrolling by invitation |
Study Name: A Prospective, Open Label, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Disease Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus Disease Condition: Acute Ebola Virus Disease Date: 2014-11-04 Interventions: Biological: INTERCEPT Plasma Plasma will be collected from eligible volunteer donors who have recovered |
Completed |
Study Name: Efficacy of Favipiravir Against Ebola (JIKI) Condition: Ebola Virus Disease Date: 2014-12-16 Interventions: Drug: Favipiravir Group A1: Day-0 (inclusion), h0: 2400 mg |
Recruiting |
Study Name: Ebola Virus Disease Survivors: Clinical and Immunologic Follow-up Condition: Ebola Virus Disease Date: 2015-04-30 |
Completed |
Study Name: A Phase I Clinical Trial to Evaluate the Ebola Adenovirus Vector Vaccine (Ad5-EBOV) in Healthy Adults. Condition: Ebola Virus Disease Date: 2014-12-22 Interventions:
|
Enrolling by invitation |
Study Name: Persistence of the Immune Response After Ebola Vaccine Immunisation Condition: Ebola Virus Disease Date: 2017-05-02 |
Enrolling by invitation |
Study Name: Clinical Trial to Evaluate the Efficacy and Safety of Convalescent Plasma for Ebola Treatment Condition: Ebola Virus Disease Date: 2015-01-05 Interventions: Procedure: Convalescent Plasma Treatment This pilot trial will treat subjects in the ECP Group with ECP |